Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 133,820 | 419,665 | 61,861 | 176,328 | 115,850 |
| Marketable Securities | 9,000 | 282,298 | 486,316 | 571,594 | 480,224 |
| Receivables | 441,273 | 346,035 | 316,339 | 304,621 | 308,455 |
| Inventories | 176,475 | 185,796 | 181,505 | 164,868 | 141,860 |
| TOTAL | $825,207 | $1,328,749 | $1,122,673 | $1,262,028 | $1,085,340 |
| Non-Current Assets | |||||
| PPE Net | 82,137 | 71,420 | 71,520 | 72,816 | 75,035 |
| Intangibles | 1,561,827 | 765,365 | 783,127 | 800,889 | 818,651 |
| Other Non-Current Assets | 56,152 | 55,698 | 76,579 | 60,799 | 84,451 |
| TOTAL | $1,700,116 | $892,483 | $931,226 | $934,504 | $978,137 |
| Total Assets | $2,525,323 | $2,221,232 | $2,053,899 | $2,196,532 | $2,063,477 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 710,685 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 20,899 | 15,360 | 18,691 | 20,074 | 10,249 |
| Accrued Expenses | 156,193 | 111,183 | 115,591 | 130,305 | 128,851 |
| TOTAL | $177,092 | $837,228 | $134,282 | $150,379 | $139,100 |
| Non-Current Liabilities | |||||
| Long Term Debt | 2,142,630 | 800,072 | 1,509,100 | 1,507,447 | 1,505,798 |
| Other Non-Current Liabilities | 113,863 | 71,799 | 77,769 | 56,436 | 54,758 |
| TOTAL | $2,299,417 | $880,089 | $1,586,869 | $1,563,883 | $1,560,556 |
| Total Liabilities | $2,476,509 | $1,717,317 | $1,721,151 | $1,714,262 | $1,699,656 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 118,017 | 117,597 | 116,966 | 123,221 | 123,153 |
| Common Shares | 118 | 118 | 118 | 123 | 123 |
| Retained earnings | 54,786 | 502,146 | 361,033 | 477,964 | 359,869 |
| Other shareholders' equity | -18,092 | -22,258 | -28,403 | -3,413 | 3,829 |
| TOTAL | $48,814 | $503,915 | $332,748 | $482,270 | $363,821 |
| Total Liabilities And Equity | $2,525,323 | $2,221,232 | $2,053,899 | $2,196,532 | $2,063,477 |